- Senior Investigator, Macromolecular Crystallography Laboratory
Dr. Ji earned his Ph.D. degree at the University of Oklahoma (1985-1990) and performed his postdoctoral research at the University of Maryland (1991-1994), where he became a Research Assistant Professor (1994-1995) before joining the National Cancer Institute (NCI), National Institutes of Health (NIH). At the NCI at Frederick, Dr. Ji established his laboratory in the ABL-Basic Research Program in 1995, moved to the Center for Cancer Research in 1999, gained tenure in 2001 as an NIH Senior Investigator, and in 2008 became a member of the Senior Biomedical Research Service (SBRS). The SBRS, established under the Public Health Service Act, was created for scientists who are considered by their peers to be outstanding in their work.
- (2013). RNase III: Genetics and Function; Structure and Mechanism. Annual Review of Genetics. 47, 405-+.
- (2012). Bisubstrate analog inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: New lead exhibits a distinct binding mode. BIOORGANIC & MEDICINAL CHEMISTRY. 20(14), 4303-4309.
- (2012). Bisubstrate analogue inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: New design with improved properties. BIOORGANIC & MEDICINAL CHEMISTRY. 20(1), 47-57.
- (2012). Crystal structure of a plectonemic RNA supercoil. Nature Communications. 3,
- (2012). P6981, An Arylstibonic Acid, Is a Novel Low Nanomolar Inhibitor of cAMP Response Element-Binding Protein Binding to DNA. MOLECULAR PHARMACOLOGY. 82(5), 814-823.